Randomized comparison of fixed-schedule versus response-oriented individualized induction therapy and use of ubenimex during and after consolidation therapy for elderly patients with acute myeloid leukemia: the JALSG GML200 Study
Phase of Trial: Phase II
Latest Information Update: 01 Jul 2012
At a glance
- Drugs Daunorubicin (Primary) ; Enocitabine (Primary) ; Ubenimex (Primary)
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- 05 Nov 2010 New trial record.